Fingerprint
Dive into the research topics of 'MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer
Stephen Johnston, Miguel Martin, Angelo Di Leo, Seock Ah Im, Ahmad Awada, Tammy Forrester, Martin Frenzel, Molly C. Hardebeck, Joanne Cox, Susana Barriga, Masakazu Toi, Hiroji Iwata, Matthew P. Goetz
Research output: Contribution to journal › Article › peer-review
112
Scopus
citations